HOXA9 and cancer: Multiple tumor suppressors were expressed at lower levels in EBVaGCs including five (TFF2, RBP4, HOXA9, LRRN1, and RAP1GAP) that are known to be hypermethylated in cancers [67], [68], [69], [70], [71].